Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.29% |
| 2 | Financials | 4.55% |
| 3 | Industrials | 4.18% |
| 4 | Healthcare | 4.08% |
| 5 | Consumer Discretionary | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
CALL
Colgate-Palmolive
CL
$73.3B
| $17.5M | 0.01% |
254,900
-113,000
| -31% | -$7.7M |
|
|
ITCI
1502
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $17.5M | 0.01% |
511,100
+451,900
| +763% | +$5.42M |
|
1503
Visteon
VC
$2.89B
| $17.5M | 0.01% |
202,509
-728,398
| -78% | -$64.9M |
|
1504
HSBC
HSBC
$357B
| $17.5M | 0.01% |
448,369
-178,019
| -28% | -$6.75M |
|
1505
Cactus
WHD
$5.88B
| $17.5M | 0.01% |
510,536
-1,007,715
| -66% | -$30.6M |
|
1506
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$310M
| $17.5M | 0.01% |
659,900
+75,200
| +13% | +$1.92M |
|
1507
PUT
Axsome Therapeutics
AXSM
$11.2B
| $17.5M | 0.01% |
169,000
+91,000
| +117% | +$3.68M |
|
1508
Ironwood Pharmaceuticals
IRWD
$712M
| $17.5M | 0.01% |
1,312,165
-1,266,004
| -49% | -$14M |
|
1509
PUT
ProShares UltraPro Short QQQ
SQQQ
$1.68B
| $17.5M | 0.01% |
1,247
+789
| +172% | +$13.5M |
|
1510
Vanguard FTSE Pacific ETF
VPL
$8.64B
| $17.5M | 0.01% |
250,803
+150,951
| +151% | +$10.4M |
|
1511
PUT
Albemarle
ALB
$16.1B
| $17.4M | 0.01% |
238,800
-32,700
| -12% | -$2.18M |
|
1512
CALL
DaVita
DVA
$11.5B
| $17.4M | 0.01% |
232,200
-141,500
| -38% | -$9.39M |
|
1513
CALL
Tilray
TLRY
$636M
| $17.4M | 0.01% |
101,700
+1,680
| +2% | +$347K |
|
1514
Match Group
MTCH
$8.71B
| $17.4M | 0.01% |
211,675
-625,528
| -75% | -$45.5M |
|
1515
CALL
Old National Bancorp
ONB
$10.4B
| $17.4M | 0.01% |
950,300
-497,800
| -34% | -$8.94M |
|
1516
FS KKR Capital
FSK
$3.42B
| $17.3M | 0.01% |
706,937
+221,764
| +46% | +$5.3M |
|
1517
CALL
Nutanix
NTNX
$18B
| $17.3M | 0.01% |
554,400
+203,000
| +58% | +$5.99M |
|
1518
CALL
Xerox
XRX
$407M
| $17.3M | 0.01% |
469,800
+302,700
| +181% | +$10.6M |
|
1519
Charles River Laboratories
CRL
$13.4B
| $17.3M | 0.01% |
+113,373
| New | +$15.7M |
|
1520
CALL
Viatris
VTRS
$18.6B
| $17.3M | 0.01% |
861,200
-250,000
| -22% | -$4.65M |
|
1521
PUT
TAL Education Group
TAL
$6.46B
| $17.3M | 0.01% |
359,000
-109,600
| -23% | -$4.71M |
|
1522
PUT
Royal Gold
RGLD
$19.5B
| $17.2M | 0.01% |
141,000
+22,300
| +19% | +$2.64M |
|
1523
CALL
Bunge Global
BG
$21.8B
| $17.2M | 0.01% |
299,500
+41,700
| +16% | +$2.31M |
|
1524
PUT
Chewy
CHWY
$9.18B
| $17.2M | 0.01% |
594,200
+6,400
| +1% | +$164K |
|
1525
JPMorgan BetaBuilders Japan ETF
BBJP
$19.1B
| $17.2M | 0.01% |
350,880
+144,673
| +70% | +$7.14M |
|
Similar funds
Ken Griffin's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Griffin held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.
Against the trend, Ken Griffin opened a new position in Interxion Holding N.V. worth $83.9M.
- Ken Griffin's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Ken Griffin added most to Amazon in Q4 2019, an estimated $615M increase.
- Ken Griffin's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Ken Griffin fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Ken Griffin's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Ken Griffin opened 1,220 new positions and closed 1,266 in Q4 2019.
- Ken Griffin's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.